Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)
Clinical trial NCT03893695 · COMPLETED
Trial details
- NCT number
- NCT03893695
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-25
- Primary completion
- 2022-05-26
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.